Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | 98 493 | déclaré | 04 mars 2026 | tx 292+1 278 850−806 278 |
| Molecular Insight Pharmaceuticals, Inc. | 25 000 | déclaré | 22 sept. 2008 | tx 1+25 000 |
| Pacira BioSciences, Inc. | 8 225 | déclaré | 08 juin 2022 | tx 18+82 944 |
| Moelis & Co | 1 156,96 | déclaré | 14 nov. 2018 | tx 50+8 539,49 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 04 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 973 | 323.84 USD | |
| 04 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 444 | 323.01 USD | |
| 04 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 368 | 321.82 USD | |
| 04 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 274 | 320.81 USD | |
| 04 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 265 | 325.67 USD | |
| 04 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 135 | 319.03 USD | |
| 04 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 345 | 324.88 USD | |
| 04 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 129 | 320.01 USD | |
| 02 mars 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 13 844 | 0.00 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 200 | 323.62 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 382 | 324.65 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 399 | 331.93 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 1 669 | 326.81 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 1 399 | 327.67 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 424 | 328.71 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 722 | 329.71 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 346 | 330.85 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 160 | 332.64 USD | |
| 02 mars 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 1 098 | 325.63 USD | |
| 02 mars 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 110 746 | 0.00 USD | deriv |
| 02 mars 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 30 425 | 0.00 USD | deriv |
| 27 févr. 2026 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 5 921 | 0.00 USD | |
| 27 févr. 2026 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 5 921 | 0.00 USD | deriv |
| 13 févr. 2026 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 6 958 | 310.08 USD | |
| 12 févr. 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 14 209 | 0.00 USD |